BioTox Bac 3
NDC 50181-0078, Mycoplasma Pneumoniae, Proteus (Vulgaris), Candida Albicans, Colibacillinum Cum Natrum Muriaticum, Mycobacterium Paratuberculosis, Pasteurellosis (Pasteurella Multocida), Pneumococcinum, Thuja Occidentalis, Mycobacterium Avium Paratuberculosis, Phytolacca Decandra, Legionella Pneumophila, Shigella Sonnei, liquid, from The Wellness Center for Research and Education, Inc..
- Product NDC
- 50181-0078
- Status
- Listed
- Labeler
- The Wellness Center for Research and Education, Inc.
- Dosage form
- LIQUID
- Route
- ORAL
- Product type
- HUMAN OTC DRUG
- Marketing category
- UNAPPROVED HOMEOPATHIC
- Application
- —
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/50181-0078 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- MYCOPLASMA PNEUMONIAE9 [hp_X]/mL
- PROTEUS INCONSTANS12 [hp_X]/mL
- CANDIDA ALBICANS15 [hp_X]/mL
- ESCHERICHIA COLI15 [hp_X]/mL
- MYCOBACTERIUM AVIUM SUBSP. PARATUBERCULOSIS15 [hp_X]/mL
- PASTEURELLA MULTOCIDA15 [hp_X]/mL
- STREPTOCOCCUS PNEUMONIAE15 [hp_X]/mL
- THUJA OCCIDENTALIS LEAFY TWIG15 [hp_X]/mL
- PHYTOLACCA AMERICANA ROOT6 [hp_C]/mL
- LEGIONELLA PNEUMOPHILA15 [hp_C]/mL
- SHIGELLA SONNEI15 [hp_C]/mL
Pharmacologic classes
Allergens [CS]; Cell-mediated Immunity [PE]; Fungal Proteins [CS]; Increased Histamine Release [PE]; Increased IgG Production [PE]; Non-Standardized Fungal Allergenic Extract [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 50181-0078-1 | 50181007801 | 30 mL in 1 BOTTLE, DROPPER (50181-0078-1) |
Linked data
RxNorm, label and prices
RxNorm concepts
RxNorm links no concept to this product's packages.
Related lookups
No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.
Use it
Look up 50181-0078 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/50181-0078 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 50181-0078. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.